Bigul

Suven Life Sciences Ltd - 530239 - Outcome Of Extra-Ordinary General Meeting (EGM) Held On 20Th March, 2021 - Reg.

This is with reference to our earlier letter dated 25th February, 2021 regarding the Extra-Ordinary General Meeting (EGM) of the Company held today i.e. Saturday, 20th March, 2021 and the business mentioned in the Notice dated February 20, 2021 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III We request you to take the documents on your record.
20-03-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that our Registrar & Transfer Agent (RTA) has received intimation from Shareholder regarding loss of share certificate(s) from the following shareholders(s) on 06th March, 2021 in turn the Company received communication from RTA in this regard today i.e. 08th March, 2021. A copy of intimation letter enclosed herewith. Name of the Holder Folio No. No. of Shares Certificate No.(s) Distinctive Nos. date of receipt of information From To DAHIBEN J PATEL SPL000737 1000 22685 107014521 107015520 08/03/2021 The above said shareholder(s) of these shares have requested the company to issue of duplicate share certificate(s) in lieu of the original share certificate(s). This is for your information and record.
08-03-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement regarding Notice of Extra-Ordinary General Meeting and E-Voting Information. In continuation to our letter dated 25th February, 2021 regarding Notice of the Extra-Ordinary General Meeting and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the copies of the newspaper advertisements regarding Notice of the Extra-Ordinary General Meeting of the Company and E-Voting Information as appeared on 26th February, 2021 in Andhra Prabha (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: http://www.suven.com/EGM.aspx. This is for your information and record.
26-02-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Preferential Issue

Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015 and other applicable provisions of law, please find enclosed the Notice of Extra-Ordinary General Meeting (EGM) of Suven Life Sciences Limited ('the Company') to be held on Saturday, 20th March, 2021 at 11.30 a.m. (IST) through video conference ('VC') / other audio-visual means ('OAVM'). The Notice of EGM has been dispatched electronically to the members whose email IDs are registered with the Company/ Depositories. The Notice of EGM is also uploaded on the Company's website at www.suven.com. This is for your information and record.
25-02-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Notice Of Extra-Ordinary General Meeting To Be Held On Saturday, 20Th March, 2021

!Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015 and other applicable provisions of law, please find enclosed the Notice of Extra-Ordinary General Meeting (EGM) of Suven Life Sciences Limited ('the Company') to be held on Saturday, 20th March, 2021 at 11.30 a.m. (IST) through video conference ('VC') / other audio-visual means ('OAVM'). The Notice of EGM has been dispatched electronically to the members whose email IDs are registered with the Company/ Depositories. The Notice of EGM is also uploaded on the Company's website at www.suven.com. This is for your information and record.
25-02-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Outcome Of The Board Meeting Under Regulation 30 Of The SEBI (LODR) Regulations, 2015

Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015, as amended and other applicable provisions of law, we wish to inform you that the Board of Directors of the company at its meeting held today i.e. 20th February, 2021 has inter-alia considered and approved the following: 1. Issuance of 1,81,00,000 (One Crore Eighty-One Lakh) fully Convertible Warrants on Preferential Basis to the Promoter/ Promoter Group (details as annexed) of the company in accordance with the provisions of the Companies Act, 2013, Chapter V of the SEBI (lssue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable statutory provisions and subject to the approval of shareholders in the Extra-Ordinary General Meeting of the Company;
20-02-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window

Intimation of Board Meeting of the Company to be held on Saturday, the 20th February, 2021 - Reg., In this connection, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended and in terms of the Code of Conduct of the Company for prevention of Insider Trading, the "Trading Window" for dealing in the securities of the Company shall remain closed for the Directors, Promoters, other Designated Persons, and immediate relatives of Designated Persons covered under the said code read with the SEBI Regulations, from 18th February 2021 to 22nd February 2021 (both days inclusive). Please further note that Trading window will be opened from 23rd February, 2021.
17-02-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Saturday, The 20Th February, 2021 - Reg.,

SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/02/2021 ,inter alia, to consider and approve With reference to above subject please note that a Meeting of the Board of Directors of the Company will be held on Saturday, the 20th February, 2021 at 10:30 a.m. for considering and approving among others the proposal to issue warrants/ Equity Shares to the Promoters / Promoter Group on Preferential Basis as provided under Chapter V of the SEBI (ICDR) Regulations, 2018. The aforesaid intimation is being submitted pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
17-02-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper advertisement - Un-audited Financial Results of the Company for quarter ended 31st December, 2020 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisement regarding Un-audited Financial Results of the Company for quarter ended 31st December, 2020. The advertisements are as appeared on 29th January, 2021 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx This is for your information and record.
29-01-2021
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Un-Audited Standalone And Consolidated Financial Results Under Ind AS For The Quarter Ended 31St December, 2020

With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 28th January, 2021, has taken on record and approved the Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter ended 31st December, 2020. We are enclosing herewith the following documents: a) Un-audited Standalone and Consolidated Financial Results under Ind AS for the quarter ended 31st December, 2020. b) Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and c) A copy of the News Release of our company Update on patents during this period can be viewed at: http://suven.com/Patentupdates.aspx We request you to take these documents on your records. The Board Meeting commenced at 11:30 A.M. and concluded at 12:45 P.M.
28-01-2021
Next Page
Close

Let's Open Free Demat Account